Title: Sub-cellular internalization and organ specific oral delivery of PABA nanoparticles by side chain variation.
Journal: Journal of nanobiotechnology 20110101
65052-85-9
7498-40-0
85367-02-8
4589-12-2
33120-20-6
1025562-02-0 | ethyl (3Z)-3-[2-(1,3-benzothiazol-2-yl)hydrazin-1-ylidene]-4,4,4-trifluorobutanoate | AA00IX8Y | MFCD00955274
934986-62-6 | 2,4,6-Trichlorophenyl 4-bromobenzenesulfonate | AA00IXE1 | MFCD12498722
477869-99-1 | ethyl 2-(1,2-oxazol-5-yl)-3-phenylpropanoate | AA00IXH4 | MFCD01814616
477872-00-7 | methyl 4-[2-(1-methyl-1H-pyrrol-2-yl)-2-oxoacetamido]benzoate | AA00IXK7 | MFCD02102452
338398-97-3 | 5-methyl-2-(pyridin-3-yl)-1,3-thiazol-4-yl 3,5-dichlorobenzoate | AA00IXOL | MFCD00172530
99325-84-5 | dimethyl[(1E)-1-nitroprop-1-en-2-yl]amine | AA00IXRB | MFCD02186820
338405-07-5 | N'-[2-(2,4-dichlorophenoxy)ethanimidoyl]benzenesulfonohydrazide | AA00IXUI | MFCD00214730
338416-84-5 | 1-Methyl-2-(m-tolyloxy)-1H-indole-3-carbaldehyde | AA00IXX5 | MFCD01315835
865658-27-1 | 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(quinolin-6-yl)-4H-1,2,4-triazole-3-thiol | AA00IXZW | MFCD04125181
167501-37-3 | (2E)-3-amino-2-cyano-N-methyl-3-(morpholin-4-yl)prop-2-enethioamide | AA00IY34 | MFCD00243957